FLAGSHIP VENTURES FUND V, L.P.

CAMBRIDGE, MA Venture Capital Fund How do I update this listing?

Create Email Alert

Flagship Ventures Fund V is based out of Cambridge. Whalewisdom has at least 9 13D filings, and 6 13G filings The firm last filed a Form D notice of exempt offering of securities on 2014-12-17. The filing was for a pooled investment fund: venture capital fund The notice included securities offered of Equity

Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Sana Biotechnology Inc (SANA) HEALTH CARE 34,239,018 282,814,288.68 1 13G 2021-12-31
Foghorn Therapeutics Inc. (FHTX) HEALTH CARE 12,674,120 193,026,847.60 2 13D 2020-10-27
Omega Therapeutics Inc (OMGA) HEALTH CARE 25,902,269 161,630,158.56 3 13D 2021-08-03
Evelo Biosciences Inc (EVLO) HEALTH CARE 50,427,328 106,905,935.36 4 13D 2022-05-27
Kaleido Biosciences Inc (KLDO) HEALTH CARE 19,575,710 32,299,921.50 5 13D 2021-02-08
Codiak BioSciences, Inc. (CDAK) HEALTH CARE 2,607,303 16,347,789.81 6 13G 2020-12-31
Sigilon Therapeutics, Inc. (SGTX) HEALTH CARE 10,370,369 15,244,442.43 7 13G 2020-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2014-12-17 D POOLED INVESTMENT FUND: VENTURE CAPITAL FUND Equity 350,000,000 0 350,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
NOUBAR B. AFEYAN, PH.D. subscription required
    EXECUTIVE OFFICER
GENERAL PARTNER LLC FLAGSHIP VENTURES FUND V subscription required
    EXECUTIVE OFFICER

Elevate your investments